Code No. |
TS-M008-1 |
T-Select H-2Kb Negative (SIY) Tetramer-SIYRYYGL-PE
|
Price |
¥209,000
|
Size |
50 tests |
Availability (in Japan) |
1-9
(In Japan at 00:05, Apr 19, 2024 in JST)
|
Class |
Class I |
Animal species |
Mouse |
Category |
negative |
Conjugate |
PE |
Immunogen (Antigen) |
SIY |
Sequence |
SIYRYYGL |
MHC Allele |
H-2Kb |
Location (aa) |
- |
Storage temp. |
4°C |
Manufacturer |
MBL |
Related products |
TS-M008-2 T-Select H-2Kb Negative (SIY) Tetramer-SIYRYYGL-APC
|
Product category |
Research area:Immunology Tools:MHC tetramer |
Citations |
- Wakita D et al. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen. Int Immunol. 18, 425-434 (2006)(PMID:16415100)
- Chamoto K et al. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy. Cancer Res. 66, 1809-1817 (2006)(PMID:16452242)
- Asano J et al. Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo. J Immunol. 184, 736-745 (2010)(PMID:20008287)
- Du X et al. A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Res. 28, 416-432 (2018)(PMID:29472691)
- Sivick KE et al. Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity. Cell Rep. 25, 3074-3085.e5 (2018)
(PMID:30540940)
|